SRF had the best quarter in its history and then spent the earnings call telling investors not to expect another one. Management used the word aberration. The stock fell 1.25% on a day the company reported a 76% jump in profit. That is an unusual thing for a company to do, and it is the most useful thing to come out of specialty chemicals Q1 FY27. Three other producers posted records in the same three months. None of them were as candid about why.
Aarti Industries sold about 12% less volume in the June quarter than in the March quarter. Its profit rose 260%.
That single pair of numbers is the most honest description of what happened to Indian specialty chemicals in Q1 FY27.
| Company | Revenue Q1 FY27 | YoY | EBITDA | PAT |
|---|---|---|---|---|
| SRF | ₹5,033 cr | +32% | ₹1,373 cr, +61% | ₹759 cr, +76% |
| Deepak Nitrite | ₹2,592 cr | +35% | ₹554 cr, +159% | +207% |
| Aarti Industries | ₹2,627 cr | +41% | ₹385 cr, +79% | ₹155 cr, +260% |
| Navin Fluorine | ₹1,045 cr | +44% | Not disclosed | ₹243 cr, +108% |
SRF called it the best quarter in the company’s history, and the numbers back that up. EBITDA margin reached 27.3%. The chemicals business grew 26% to ₹2,315 crore, but the bigger jump came from Performance Films and Foil, up 42% to ₹2,017 crore. Management then did something unusual: it told the market not to extrapolate. The quarter was described as an aberration, driven by running at full capacity while competitors dealt with disruption. Chemicals guidance for FY27 stayed at 15% to 20%.
Deepak Nitrite posted its strongest quarter on record. EBITDA margin went from 11% a year ago to 21%. Management put it down to integration benefits from the polycarbonate chain rather than pricing, which if true is the most durable improvement of the four. The company commissioned MIBK, MIBC and acetophenone in August, with an agrochemical intermediate facility due in Q2. Capex for FY27 is guided at ₹1,500 to 1,600 crore, with about ₹6,000 crore planned through FY28.
Aarti Industries is the one to read carefully. Revenue up 41%, EBITDA up 79%, profit up 260%, and volumes down 12% sequentially. Energy segment volumes fell 17%, non-energy 7%. The company was straightforward about where the profit came from: optimised product mix, inventory gains and forex. Exports were 59% of revenue. Fuel additives capacity went from 290 to 360 KTPA in July. Several projects slipped three to six months on labour constraints and war-related disruption.
Navin Fluorine doubled profit on 44% revenue growth, with capex still ramping across its verticals.
Where the money came from
Three things happened at once, and none of them was a demand recovery.
Fuel and freight costs rose on West Asia disruption. That sounds like a headwind, and for anyone buying crude-linked feedstock it was. But it also lifted the price of everything already sitting in the tank. Companies holding inventory bought at old prices and selling at new ones booked the difference as margin. Aarti named inventory gains directly. That money is real, and it is not repeatable.
Supply chains broke for somebody else. SRF spelled this out: it ran at 100% capacity while competitors faced disruption. When your rivals cannot ship, your pricing power improves without you doing anything differently.
And the rupee moved. Forex gains showed up across the group, most explicitly at Aarti, where exports are 59% of revenue.
Strip those three out and what remains is a sector growing at something closer to its guided 15% to 20%, not the 32% to 44% the headline revenue lines show.
Why the caution matters more than the numbers
It is rare for a company to post a record quarter and then talk it down. SRF did exactly that, and the stock fell 1.25% on the day of the results despite a 76% profit jump. The market heard the warning.
That is the right reaction, and it points at the real issue with reading this sector. Specialty chemicals margins swing on inventory timing, feedstock spreads and who else is having a bad quarter. Volume tells you about demand. Margin often tells you about disruption. In Q1 FY27 the two moved in opposite directions at Aarti, which is the clearest possible signal about which force was dominant.
The China question sits underneath all of it. Aarti flagged excess capacity in China as a persistent condition, and SRF’s specialty chemicals business described a market of shifting global pricing. Chinese overcapacity has been compressing Indian specialty chemical margins for three years. A quarter of disrupted freight does not change that; it postpones it.
What is actually being built
Behind the noisy quarter, the capex is the durable story.
Deepak Nitrite is committing roughly ₹6,000 crore through FY28 on integration down the polycarbonate chain, which is a structural margin change rather than a cyclical one. Aarti completed its fuel additives expansion and has the Superform joint venture and a chemical recycling project due over FY27. Navin Fluorine is ramping capex across all verticals. SRF approved ₹250 crore for a BOPET thick film line and holds 159 granted patents with 528 applied.
That is a sector spending on capability while a windfall pays for it, which is the right order to do things in.
What to watch
Whether Q2 normalises the way SRF says it will. Management has effectively pre-announced a weaker sequential quarter. If it comes in flat or better, the pricing gains were more durable than anyone expected.
Whether Aarti’s volumes recover. A 12% sequential drop attributed to West Asia should reverse quickly if that is the whole explanation. If it does not, the problem is demand, not shipping.
Whether Deepak Nitrite holds 21%. Integration-led margin should survive a normalising cost environment in a way that inventory gains will not.
Specialty chemicals Q1 FY27 was a very good three months. Very little of it was earned in the ordinary sense, and the companies that said so out loud are the ones worth trusting on what comes next.
All figures as reported for the quarter ended 30 June 2026.